HistoSonics
MI - Ann ArborBiotechnology
Focus: HistoSonics is a publicly-listed medical device biotech specializing in non-invasive, autonomous robotic platforms using histotripsy technology for oncology and benign disease treatment. The company operates a focused pipeline across multiple solid tumor indications and benign prostatic hyperplasia.
Profile data last refreshed 17h ago · AI intelligence enriched 5d ago
Funding Stage
PUBLIC
Open Jobs
20+1 this month
Stable — net +1 jobs in 30d
32 added, 31 removed. Backfill posture.
Should You Work at HistoSonics?
AI assessmentBest for engineers and device commercialization specialists seeking growth-stage stability; less attractive for clinical or drug-development-track careers given sparse near-term catalysts.
Why Work Here
- Public company status provides equity stability and potential liquidity absent in most early-stage biotechs.
- Diversified pipeline across 5+ cancer indications (pancreas, colorectal, liver, renal) plus BPH signals broad platform potential and multiple value inflection points.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
12 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
HistoSonics Edison® System
Colorectal CancerClinical Trials (1)
NCT07044362Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
N/AHelp build intelligence for HistoSonics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.